Pluribus Labs’s IBM IBM Stock Holding History

Pluribus Labs’s Portfolio IBM Stock Details IBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$417K	Buy	2,951 +493	+20%	+$66.5K	0.76%	35
2022 Q1	$320K	Buy	+2,458	New	+$321K	1.27%	26

Other funds holding IBM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pluribus Labs's IBM Position: Q2 2022 in Review

Pluribus Labs increased its IBM (IBM) stake by 20% in Q2 2022, buying an estimated $66.5K and bringing the position to 2,951 shares worth $417K. The position accounts for 0.76% of the portfolio, ranked #35.

Pluribus Labs first reported a position in IBM in Q1 2022 and has held it in 2 quarters since. 2,375 funds tracked by Wall St. Rank hold IBM as of Q2 2022.

Pluribus Labs held 2,951 shares of IBM worth $417K as of Q2 2022.
Pluribus Labs bought 493 IBM shares in Q2 2022, an estimated $66.5K.
IBM made up 0.76% of Pluribus Labs's portfolio in Q2 2022, its #35 holding.
Pluribus Labs first reported a position in IBM in Q1 2022 and has held it in 2 quarters since.
2,375 funds tracked by Wall St. Rank held IBM as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.